Cargando…

How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients

BACKGROUND: Nipple-sparing mastectomy (NSM) offers superior cosmetic outcomes and has been gaining wide acceptance. It has always been difficult to objectively quantify the risk of nipple-areola complex involvement (NACi). The goal was to develop a prediction model for clinical application. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuanbing, Pan, Dai, Liu, Yi, Liu, Hanzhong, Sun, Xing, Zhang, Wenjie, Hu, Chaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976364/
https://www.ncbi.nlm.nih.gov/pubmed/36855131
http://dx.doi.org/10.1186/s12957-023-02949-3
_version_ 1784899053005307904
author Xu, Yuanbing
Pan, Dai
Liu, Yi
Liu, Hanzhong
Sun, Xing
Zhang, Wenjie
Hu, Chaohua
author_facet Xu, Yuanbing
Pan, Dai
Liu, Yi
Liu, Hanzhong
Sun, Xing
Zhang, Wenjie
Hu, Chaohua
author_sort Xu, Yuanbing
collection PubMed
description BACKGROUND: Nipple-sparing mastectomy (NSM) offers superior cosmetic outcomes and has been gaining wide acceptance. It has always been difficult to objectively quantify the risk of nipple-areola complex involvement (NACi). The goal was to develop a prediction model for clinical application. METHODS: Patients who had a total mastectomy (TM) between January 2016 and January 2020 at a single institute formed the development cohort (n = 578) and those who had NSM + immediate breast reconstruction (IBR) between January 2020 and January 2021 formed the validation cohort (n = 112). The prediction model was developed using univariate and multivariate logistic regression studies. Based on NACi risk variables identified in the development cohort, a nomogram was created and evaluated in the validation cohort. Meanwhile, stratified analysis was performed based on the model’s risk levels and was combined with intraoperative frozen pathology (IFP) to optimize the model. RESULTS: Tumor central location, clinical tumor size (CTS) > 4.0 cm, tumor-nipple distance (TND) ≤ 1.0 cm, clinical nodal status positive (cN +), and KI-67 ≥ 20% were revealed to be good predictive indicators for NACi. A nomogram based on these major clinicopathologic variables was employed to quantify preoperative NACi risk. The accuracy was verified internally and externally. The diagnostic accuracy of IFP was 92.9%, sensitivity was 64.3%, and specificity was 96.9% in the validation group. Stratified analysis was then performed based on model risk. The diagnostic accuracy rates of IFP and NACiPM in low-risk, intermediate-risk, and high-risk respectively were 96.0%, 93.3%, 83.9%, 61.3%, 66.7%, and 83.3%. CONCLUSION: We created a visual nomogram to predict NACi risk in breast cancer patients. The NACiPM can be used to distinguish the low, intermediate, and high risk of NAC before surgery. Combined with IFP, we can develop a decision-making system for the implementation of NSM.
format Online
Article
Text
id pubmed-9976364
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99763642023-03-02 How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients Xu, Yuanbing Pan, Dai Liu, Yi Liu, Hanzhong Sun, Xing Zhang, Wenjie Hu, Chaohua World J Surg Oncol Research BACKGROUND: Nipple-sparing mastectomy (NSM) offers superior cosmetic outcomes and has been gaining wide acceptance. It has always been difficult to objectively quantify the risk of nipple-areola complex involvement (NACi). The goal was to develop a prediction model for clinical application. METHODS: Patients who had a total mastectomy (TM) between January 2016 and January 2020 at a single institute formed the development cohort (n = 578) and those who had NSM + immediate breast reconstruction (IBR) between January 2020 and January 2021 formed the validation cohort (n = 112). The prediction model was developed using univariate and multivariate logistic regression studies. Based on NACi risk variables identified in the development cohort, a nomogram was created and evaluated in the validation cohort. Meanwhile, stratified analysis was performed based on the model’s risk levels and was combined with intraoperative frozen pathology (IFP) to optimize the model. RESULTS: Tumor central location, clinical tumor size (CTS) > 4.0 cm, tumor-nipple distance (TND) ≤ 1.0 cm, clinical nodal status positive (cN +), and KI-67 ≥ 20% were revealed to be good predictive indicators for NACi. A nomogram based on these major clinicopathologic variables was employed to quantify preoperative NACi risk. The accuracy was verified internally and externally. The diagnostic accuracy of IFP was 92.9%, sensitivity was 64.3%, and specificity was 96.9% in the validation group. Stratified analysis was then performed based on model risk. The diagnostic accuracy rates of IFP and NACiPM in low-risk, intermediate-risk, and high-risk respectively were 96.0%, 93.3%, 83.9%, 61.3%, 66.7%, and 83.3%. CONCLUSION: We created a visual nomogram to predict NACi risk in breast cancer patients. The NACiPM can be used to distinguish the low, intermediate, and high risk of NAC before surgery. Combined with IFP, we can develop a decision-making system for the implementation of NSM. BioMed Central 2023-03-01 /pmc/articles/PMC9976364/ /pubmed/36855131 http://dx.doi.org/10.1186/s12957-023-02949-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Yuanbing
Pan, Dai
Liu, Yi
Liu, Hanzhong
Sun, Xing
Zhang, Wenjie
Hu, Chaohua
How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title_full How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title_fullStr How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title_full_unstemmed How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title_short How to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
title_sort how to accurately preoperative screen nipple-sparing mastectomy candidate—a nomogram for predicting nipple-areola complex involvement risk in breast cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976364/
https://www.ncbi.nlm.nih.gov/pubmed/36855131
http://dx.doi.org/10.1186/s12957-023-02949-3
work_keys_str_mv AT xuyuanbing howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT pandai howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT liuyi howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT liuhanzhong howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT sunxing howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT zhangwenjie howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients
AT huchaohua howtoaccuratelypreoperativescreennipplesparingmastectomycandidateanomogramforpredictingnippleareolacomplexinvolvementriskinbreastcancerpatients